Overactive responses by interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) are tightly linked to the development of autoimmunity, yet the factors that negatively regulate the differentiation of this lineage remain unknown. Here we report that the transcription factor T-bet suppressed development of the T H 17 cell lineage by inhibiting transcription of Rorc (which encodes the transcription factor RORγt). T-bet interacted with the transcription factor Runx1, and this interaction blocked Runx1-mediated transactivation of Rorc. T-bet Tyr304 was required for formation of the T-bet-Runx1 complex, for blockade of Runx1 activity and for inhibition of the T H 17 differentiation program. Our data reinforce the idea of master regulators that shape immune responses by simultaneously activating one genetic program while silencing the activity of competing regulators in a common progenitor cell.
A r t i c l e s The signals received during an infection trigger a strong adaptive immune response tailored to combat a particular class of pathogen. In the presence of cytokines produced by cells of innate immunity, naive CD4 + T cells differentiate into a helper T cell subset with distinct functions and cytokine profile. Two main helper T cell subsets, T H 1 and T H 2, were the first described 1 . T H 1 cells, which secrete mainly interferon-γ (IFN-γ), are essential for immunity against intracellular microorganisms, whereas T H 2 cells, which secrete interleukin 4 (IL-4), IL-5 and IL-13, are important for protection against parasites and extracellular pathogens. A third subset of helper T cells, T H 17, has also been described [2] [3] [4] [5] [6] [7] . T H 17 cells produce IL-17A, IL-17F, IL-21 and IL-22, which protect the host against bacterial and fungal infections encountered at mucosal surfaces 8 . In mice, T H 17 differentiation is initiated by the combination of transforming growth factor-β (TGF-β) and IL-6 or IL-21, which induces expression of the T H 17 cell-specific transcription factor RORγt and the receptor for IL-23 (IL-23R) 7, [9] [10] [11] [12] . This acquisition of responsiveness to IL-23 is necessary for terminal differentiation of the T H 17 cell lineage and for the maintenance of T H 17 function in vivo 13 .
In general, lineage-specific transcription factors and cytokines can inhibit the differentiation of other helper T cell subsets. T-bet suppresses the generation of T H 2 cells by blocking expression of the T H 2-polarizing cytokine IL-4 and by interfering with the activity of the T H 2-cell-specific transcription factor GATA- 3 (refs. 14,15) . The results of several studies have indicated that T H 17 responses are stronger in T-bet-deficient animals, although the mechanism underlying this phenomenon has not been described [16] [17] [18] [19] . This raises the question of whether, analogous to its role in inhibiting the T H 2 pathway, T-bet also actively suppresses T H 17 differentiation. Furthermore, several studies have reported that the reprogramming of committed T H 20, 21 .
cells and T H 2 cells into effector cells with a T H 17-T H 1 or T H 2-T H 1 phenotype is driven by T-bet in response to inflammatory cytokines such as IL-12 and interferons
In this study we sought to determine whether T-bet has a regulatory role in the development of the T H 17 lineage. Here we investigate the T H 17 differentiation of T-bet-deficient (Tbx21 −/− ) and wild-type CD4 + T cells in vitro and in vivo during experimental autoimmune encephalomyelitis (EAE). We found that T-bet had a negative effect on expression of the gene encoding RORγt (Rorc) and genes encoding T H 17 cytokines. Ectopic expression of T-bet in naive helper T cell precursors or in committed T H 17 cells was sufficient to repress the expression of Rorc and genes encoding T H 17 signature cytokines under T H 17-polarizing conditions. Mechanistic studies showed that interaction of T-bet with the transcription factor Runx1 via the T-bet residue Tyr304 was critical for blocking Runx1-mediated transactivation of the Rorc promoter and for inhibiting commitment to the T H 17 lineage.
RESULTS
T-bet deficiency promotes IL-17A production in vitro T-bet is a transcriptional activator of IFN-γ and is the key regulator of the T H 1 differentiation program 22 . In addition to promoting the differentiation of naive CD4 + T cells into the T H 1 subset, T-bet actively suppresses development of the T H 2 lineage 14, 15 . To investigate whether T-bet expression has a similar antagonistic effect on the development of IL-17A-producing helper T cells, we cultured A r t i c l e s Tbx21 −/− and wild-type CD4 + T cells under nonskewing conditions or differentiated them into T H 1 cells or into T H 17 cells grown in the presence or absence of IL-23. As IFN-γ has a negative effect on the polarization of T H 17 cells and Tbx21 −/− T cells produce much less IFN-γ than do wild-type CD4 + T cells, we also tested IFN-γ-deficient (Ifng −/− ) helper T cells to delineate effects of T-bet versus IFN-γ on T H 17 development. After differentiating Tbx21 −/− , Ifng −/− and wildtype cells for 5 d in vitro under T H 0, T H 1 or T H 17 conditions or under T H 17 conditions with IL-23, we briefly stimulated them with phorbol myristate acetate (PMA) and ionomycin. We observed a higher percentage of IL-17A-producing cells in T-bet-deficient T H 0 and T H 1 cultures than in Ifng −/− and wild-type cultures ( Fig. 1a) . Although we detected a similar percentage of IL-17A-producing cells under T H 17-polarizing conditions, more IL-17A was secreted by Tbx21 −/− helper T cells than by Ifng −/− and wild-type helper T cells under all differentiating conditions ( Fig. 1b) .We did not observe a substantial difference among the helper T cell subsets in Rorc mRNA expression at 24 h after activation (data not shown). However, the enhanced IL-17A production by Tbx21 −/− T H 0 and T H 1 cultures correlated with their twofold higher expression of Rorc mRNA after 5 d of culture. In contrast, Tbx21 −/− , Ifng −/− and wild-type T H 17 cells had similar expression of Rorc mRNA (Fig. 1c) . These results show that T-bet deficiency promotes the development of IL-17A-producing cells under all polarizing conditions independently of IFN-γ and suggest that T-bet-mediated effects on the generation of IL-17A-producing cells in vitro may be achieved through the transcriptional regulation of Rorc and/or Il17a in T H 0-T H 1 and T H 17 cells.
T H 17 responses in Tbx21 −/− and wild-type mice during EAE Tbx21 −/− mice are protected from the development of EAE 23 . When the results of that study 23 were first reported, T H 17 cells were yet to be discovered, and the resistance of Tbx21 −/− mice to central nervous system (CNS)-specific autoimmune attack was ascribed to a polarization shift of CD4 + T cells from a pathogenic T H 1 response to a protective T H 2 response 23 . Given the propensity of T-bet-deficient CD4 + T cells to develop into IL-17A-producing cells in vitro, we investigated whether Tbx21 −/− mice generate T H 17 responses during EAE, whose pathology is widely accepted to be dependent on T H 17 cells. To determine the types of cytokines produced by CNS-infiltrating CD4 + T cells, we stained intracellular cytokines in mononuclear cells isolated from the CNS of Tbx21 −/− and wild-type mice during the peak of disease (day 17 after immunization with a myelin oligodendrocyte glycoprotein peptide of amino acids ) plus complete Freund's adjuvant (CFA)). In wild-type mice, three different cytokine-producing populations entered the CNS: those that produced IFN-γ alone (most CD4 + T cells), those that produced only IL-17A and those that produced both cytokines ( Fig. 2a) . In contrast, in the CNS of Tbx21 −/− mice, IL-17A-producing CD4 + T cells represented most of the cytokine-producing cells at day 17 after immunization ( Fig. 2a) . Consistent with the idea of role for T-bet in controlling expression of Ifng, there was a deficiency in IFN-γ-producing CD4 + T cells in the CNS of Tbx21 −/− mice ( Fig. 2a) . Collectively, there was a shift in the T H 1-T H 17 balance in the CNS of Tbx21 −/− mice during EAE characterized by a tendency toward the recruitment of T H 17 cells and a significantly lower frequency and absolute number of IFN-γproducing CD4 + T cells ( Fig. 2b) . Moreover, CD4 + T cells isolated from the CNS of Tbx21 −/− mice secreted significantly more IL-17A than did wild-type CD4 + T cells at day 17 after immunization ( Fig. 2c) . Thus, there was recruitment of IL-17A-secreting T H 17 cells into the CNS of Tbx21 −/− mice.
IL-23R signaling drives the pathogenic potential of CNS-infiltrating T H 17 cells by promoting the expression of proinflammatory chemokines and by suppressing IL-10 expression 4, 24 . In addition, IL-23R signaling is essential for the terminal differentiation of T H 17 cells and their long-term survival 13, 25 . To address the role of T-bet in controlling IL-23R expression in T H 17 cells, we crossed reporter mice that express green fluorescent protein (GFP)-tagged IL-23R (IL-23R. GFP) onto a T-bet-deficient background. On day 17 after immunizing Tbx21 −/− and wild-type IL-23R.GFP reporter mice with MOG(35-55) plus CFA, we isolated mononuclear cells from the draining lymph nodes, spleen and CNS and determined the percentage of IL-23R + cells in the CD4 + population by flow cytometry. The Tbx21 −/− mice had higher percentage of IL-23R + CD4 + cells in the lymph nodes and the CNS than did the control wild-type mice, whereas in spleen the frequency of IL-23 + CD4 + T cells was similar ( Fig. 2d ). In addition, there was a significantly higher percentage of CD4 + cells expressing the T H 17-specific chemokine receptor CCR6 in the lymph nodes and CNS of Tbx21 −/− mice ( Fig. 2d) . We assessed the expression of genes encoding other T H 17 signature molecules in purified CD4 + T cells isolated from the CNS of Tbx21 −/− and wild-type mice during the disease peak and observed more transcripts of Rorc, Il23r, Il17a and Il17f in Tbx21 −/− CD4 + T cells, whereas the amount of Il21 and Il22 transcripts was more variable in Tbx21 −/− versus wild-type mice ( Fig. 2e) . The enhanced T H 17 response in Tbx21 −/− mice could have A r t i c l e s been intrinsic to the T cell or could have reflected differences in cytokine production by innate immune cells that could create a milieu more conducive to the polarization of T H 17 cells in vivo. To differentiate between those two possibilities, we did functional analysis of CD4 + T cells in the CNS 14 d after EAE induction using cells from mice with and without T cell-specific deletion of loxP-flanked Tbx21 alleles by Cre recombinase driven by the Cd4 promoter ( Supplementary  Fig. 1 ). We found that T cell-specific deletion of T-bet resulted in an augmented T H 17 response in the CNS during EAE, which suggested that this is a T cell-intrinsic phenomenon. Thus, a dominant T H 17 response is generated in Tbx21 −/− mice after immunization with MOG(35-55) plus CFA, which suggests that T-bet expression limits the magnitude of T H 17 responses in the CNS during EAE.
T-bet expression blocks T H 17 differentiation
The results reported above suggested that T-bet negatively regulates commitment to the T H 17 lineage. To directly assess whether T-bet has a negative role in T H 17 differentiation, we activated naive CD4 + T cells (CD62L hi CD25 lo ) under T H 17-polarizing conditions. After 24 h, we transduced activated CD4 + cells with empty retrovirus or expressing GFP alone or retrovirus expressing GFP and T-bet in cultures containing T H 17-skewing cytokines plus neutralizing antibodies to IL-4 and IFN-γ. After culturing cells for 5 d under T H 17-polarizing conditions, we assessed the cytokine production of sorted GFP + cells by intracellular cytokine staining. Transduction of either Tbx21 −/− or wild-type naive CD4 + T cells with T-bet resulted in a much lower frequency of IL-17Aproducing cells and a much greater frequency of cells producing both IFN-γ and IL-17A or IFN-γ alone ( Fig. 3a) . T-bet expression resulted in much lower expression of Rorc, RORγt target genes (Il17a and Il17f), Il21 and Il23r (Fig. 3b) . Although we observed no substantial difference between Tbx21 −/− and wild-type T H 17 cells in the amount of Il22 transcripts, T-bet overexpression augmented Il22 mRNA expression in both Tbx21 −/− and wild-type T H 17 cells ( Fig. 3b ). Ectopic expression of T-bet therefore prevents the differentiation of helper T cell precursors into T H 17 cells under T H 17-polarizing conditions by blocking expression of Rorc and, consequently, RORγt target genes. In a separate series of experiments, we used a transgenic inducible T-bet expression system in which T-bet is induced in naive helper T cell precursors in response to treatment with doxycycline. We activated naive CD4 + T cells for 24 h under T H 17-polarizing conditions. On day 2, we induced T-bet expression by administering 0.5 µg/ml of doxycycline in the presence or absence of neutralizing antibody to IFN-γ. We measured Rorc and Tbx21 mRNA and RORγt and T-bet protein by real-time PCR and immunoblot analysis, respectively. Rorc mRNA (RU) 
A r t i c l e s
Induction of T-bet expression in transgenic helper T cell precursors by doxycycline treatment resulted in a much lower abundance of Rorc transcripts and RORγt protein under T H 17-polarizing conditions ( Fig. 3c,d) . We observed suppression of RORγt by T-bet even in the presence of neutralizing antibody to IFN-γ, which demonstrated that this mode of RORγt suppression is independent of IFN-γ. T-bet can redirect fully differentiated T H 2 cells into the T H 1 pathway 22 . To determine whether T-bet could similarly reprogram committed T H 17 cells, we differentiated naive CD4 + T cells (CD62L hi CD25 lo ) under T H 17-polarizing conditions for 6 d, then reactivated Tbx21 −/− and wildtype T H 17 cells for 24 h and transduced them with empty retrovirus expressing GFP alone or retrovirus expressing GFP and T-bet under T H 17-polarizing conditions. We sorted GFP + cells 48 h after retroviral transduction and examined intracellular cytokines. We found 50% fewer IL-17A-producing cells and a greater frequency of IFN-γ-producing cells after transduction with T-bet-expressing retrovirus (Fig. 3e) . Similar to the results reported above, enforced T-bet expression in fully differentiated T H 17 cells resulted in fewer transcripts of Rorc, Il17a, Il17f, Il21 and IL23r and higher expression of Il22 (Fig. 3f) . These results indicate that ectopic expression of T-bet is sufficient to suppress expression of genes encoding T H 17 signature cytokines in committed T H 17 cells even in the presence of T H 17-polarizing cytokines.
T-bet inhibits Runx1 activity
Our results above supported the idea that the negative effect of T-bet on T H 17 differentiation could be mediated by inhibition of RORγt. To determine whether T-bet binds to the Rorc promoter, we did chromatin-immunoprecipitation (ChIP) assays of T-bet-bound chromatin from nuclear lysates of nonpolarized T H 0 cells and differentiated T H 1 and T H 17 cells. We detected modest but reproducible binding of T-bet to a site located approximately 2 kilobases (kb) upstream of the first exon of Rorc (the thymusspecific isoform) in nonskewed T H 0 cells and found considerable enrichment of T-bet bound to that same site in T H 1 cells ( Fig. 4a,b) . We did not detect binding of T-bet to the Rorc or Ifng promoter in T H 17 cells (data not shown). To test whether T-bet directly inhibits Rorc expression, we did reporter luciferase assays in HEK293 human embryonic kidney cells with a luciferase reporter spanning 2 kb upstream of Rorc exon 1. Transfection of T-bet had no effect on the activity of the Rorc luciferase reporter (Fig. 4c) , which indicated that T-bet might not directly suppress Rorc transcription. T-bet generally does not act as a direct transcriptional repressor 15, 26, 27 . Instead, T-bet exerts its negative effect on gene expression by binding to and sequestering transcriptional activators away from regulatory regions 15, [26] [27] [28] [29] . Runx1 induces Rorc expression 30 , and there are two Runx1-binding sites immediately upstream of the T-betbinding site (2 kb upstream of Rorc exon 1). That prompted us to investigate whether T-bet could inhibit Rorc expression by blocking the transcriptional activity of Runx1. To analyze the regulation of Rorc, we transfected HEK293 cells with the Rorc luciferase reporter construct described above in the presence of increasing concentrations of Runx1 plasmid with or without a T-bet expression vector. Runx1 expression increased luciferase activity in a dose-dependent manner, and this was blocked by coexpression of T-bet ( Fig. 4c) . Furthermore, T-bet blocked Runx1-mediated transactivation of the Rorc promoter in a dose-dependent manner (Fig. 4d) . Several other transcription factors (IRF4, BATF and STAT3) control T H 17 differentiation by positively regulating Rorc expression [31] [32] [33] . The expression Fig. 2) . It is unknown at present whether regulation of Rorc expression by IRF4 and BATF is mediated by direct binding of these transcription factors to the Rorc locus, but the binding sites for STAT3 in the Rorc and Il17a loci have been defined 33 . To assess the binding of STAT3 to its target sequences in the Rorc and Il17a loci, we did ChIP of STAT3bound chromatin from nuclear lysates of nonpolarized T H 0 and T H 17 cells. The binding of STAT3 to its target sites in the intergenic and intragenic regions of the Rorc locus and Il17a locus was similar in Tbx21 −/− and wild-type T H 0 and T H 17 cells ( Supplementary  Fig. 3) . These data suggest that interference with the transcriptional activity of Runx1 is the likely mechanism by which T-bet blocks Rorc expression, but interference with STAT3 is not.
T-bet interacts with Runx1
To examine further the mechanism of T-bet-mediated repression of Rorc expression, we investigated whether T-bet interacted with Runx1. First, we overexpressed T-bet with Myc-tagged Runx1, Runx2 or Runx3 in HEK293 cells and did coimmunoprecipitation experiments. T-bet interacted with both Runx1 and Runx3, but not with Runx2, in HEK293 cells (Fig. 5a) .
To determine in which helper T cell subset T-bet and Runx1 interact, we did immunoblot analysis of the expression of Runx1 and T-bet in unskewed T H 0 and differentiated T H 1 and T H 17 cells. We detected expression of T-bet and Runx1 in nonpolarized T H 0 cells (Fig. 5b) . There was much lower expression of Runx1 in T H 1 cells differentiated in vitro and, conversely, much less T-bet in T H 17 cells differentiated in vitro (Fig. 5b) .
These data suggested that T-bet and Runx1 could interact in nonpolarized T H 0 cells in which both proteins were coexpressed. Indeed, Runx1-immunoprecipitation confirmed the presence of an endogenous T-bet-Runx1 interaction in nonpolarized wild-type T H 0 cells but not in differentiated T H 1 or T H 17 cells ( Fig. 5c and data not shown). We also confirmed interaction between T-bet and Runx1 in uncommitted T H 0 cells in reverse coimmunoprecipitation assays (Fig. 5c) 
. These data suggest that a functionally important interaction between T-bet and Runx1 most probably occurs in uncommitted helper T cells but not in fully differentiated T H 1 and T H 17 cells because of restrictive expression of Runx1 and T-bet, respectively, in those helper T cells.
On the basis of our luciferase data and coimmunoprecipitation results, we hypothesized that interaction between T-bet and Runx1 could block the binding of Runx1 to its consensus sites located 2 kb upstream of the Rorc exon 1. We detected binding of Runx1 to an oligonucleotide containing wild-type Runx1 target sequence but not to an oligonucleotide in which the Runx1 target sequence was mutated by a T-to-A substitution (Fig. 5d) . T-bet bound to a wildtype oligonucleotide containing a T-bet-specific half-site but not to an oligonucleotide in which the T-bet half-site was mutated (Fig. 5d) . After confirming that the binding of Runx1 and T-bet to the site 2 kb upstream of the Rorc exon 1 was sequence specific, we did a DNAprecipitation assay with the wild-type oligonucleotide and Runx1 in the presence or absence of increasing concentrations of T-bet. In the absence of T-bet, Runx1 bound strongly to the oligonucleotide containing the wild-type Runx1-binding site (Fig. 5e) . Increasing concentrations of T-bet ablated the ability of Runx1 to bind to its target sequence in a dose-dependent manner (Fig. 5e) , which showed that interaction of T-bet with Runx1 interferes with the binding of Runx1 to its site 2 kb upstream of the Rorc exon 1. (Fig. 6a,b) . Overexpression of Runx1 reversed the inhibitory effect of T-bet and fully restored T H 17 polarization in cells coexpressing Runx1 and T-bet. However, Rorc expression was only partially upregulated ( Fig. 6b) , which suggested that there may be additional mechanisms by which T-bet inhibits Rorc transcription in T H 17 cells. Conversely, transduction of purified Tbx21 −/− CD4 + T cells with a retrovirus expressing dominant negative Runx1 during T H 17 differentiation reversed the effects of T-bet deficiency on IL-17A production by T H 17 cells (Supplementary Fig. 4) .
Runx1 reverses the effect of T-bet on T H 17 polarization
In addition to directly promoting Rorc expression, Runx1 also acts as a coactivator, and together with RORγt, it induces expression of Il17a and Il17f 30 . T-bet suppressed T H 17 differentiation by inhibiting Rorc expression ( Fig. 3) . However, it is possible that the interaction of T-bet with Runx1 serves to sequester this transcriptional coactivator and blocks the expression of genes encoding T H 17 signature cytokines in this manner. To investigate that possibility, we sought to determine whether RORγ t was able to restore a T H (Fig. 6c,d) . We were unable to coimmunoprecipitate T-bet and RORγt in HEK293 cells, which suggested that sequestration of RORγt from its target genes by T-bet is unlikely. These data demonstrate that in addition to inhibiting Rorc transcription, the interaction of T-bet with Runx1 depletes the pool of free Runx1 available for the formation of transcriptionally active Runx1-RORγt complexes in T H 17 cells.
developmental program in helper T cells coexpressing T-bet and RORγ t under T H 17polarizing conditions. Expression of RORγt independently of a T-bet transcriptional block (from retroviral long terminal repeat control elements) in developing T H cells was unable to fully reverse the T-bet-mediated inhibition of T H differentiation

T-bet Tyr304 is crucial for the suppression of T H 17 cells
To investigate which amino acid residue is important for formation of the T-bet-Runx1 complex, we tested the ability of a series of T-bet mutants to interact with Runx1 in HEK293 cells. Two of these mutants with point substitution, T-bet(S508A) and T-bet(Y525F), have been shown before to be functionally important in the repression of Il2 transcription in T H 1 cells and in T H 2 lineage suppression, respectively 15, 27 . Coimmunoprecipitation studies showed that Runx1 interacted with the mutants T-bet(Y265F), T-bet(S508A) and T-bet(Y525F) but not with the T-bet(Y304F) mutant (Fig. 7a) . Furthermore, T-bet(Y304F) was unable to suppress Runx1 transcriptional activity in the luciferase assay described above (luciferase reporter ~2 kb upstream of Rorc exon 1; Fig. 7b ), which suggested that T-bet Tyr304 may be important for the suppression of commitment to the T H 17 lineage. To clarify this, we activated sorted naive helper T cells for 24 h under T H 17-polarizing conditions and transduced them with control retrovirus or retrovirus encoding wild-type T-bet, T-bet(Y304F) or T-bet(Y525F) (control mutant). We cultured the transduced cells under T H 17-polarizing conditions for an additional 5 d and determined the frequency of IFN-γ-and IL-17-producing cells by intracellular cytokine staining. Wild-type T-bet and the T-bet(Y525F) control mutant suppressed T H 17 differentiation under T H 17-polarizing conditions. In contrast, the Y304F substitution abrogated the ability of T-bet to repress T H 17 lineage commitment (Fig. 7c) . In contrast to wild-type T-bet and the T-bet(Y525F) mutant, T-bet(Y304F) was unable to suppress expression of Rorc, Il17a, Il17f and Il23r in developing T H 17 cells (Fig. 7d) . These data indicate that T-bet Tyr304 is important for the formation of the T-bet-Runx1 complex, for the inhibition of Runx1 transcriptional activity and for the suppression of T H 17 lineage development.
In DNA-precipitation assays, the T-bet(Y304F) mutant failed to bind to the T-bet-binding site in the region 2 kb upstream of the Rorc exon 1 (Fig. 7e) , which suggested that this residue is also important for the binding of T-bet to DNA. To delineate whether T-bet-mediated inhibition of Runx1 activity was dependent on binding to DNA or the T-bet-Runx1 (protein-protein) interaction, we investigated whether wild-type T-bet inhibited the binding of Runx1 to its target site; for this, we used oligonucleotides in which the T-bet-binding site was mutated. T-bet blocked the binding of Runx1 to the Runx1specific sequence independently of the ability of T-bet to bind to DNA (Fig. 7f) . Collectively, these data suggest that the T-bet-Runx1 (protein-protein) interaction is mainly responsible for the inhibition of Runx1 activity, with the T-bet (protein)-DNA interaction having a minor (if any) role.
DISCUSSION
Lineage-specific transcription factors can both activate and repress differentiation programs. T-bet simultaneously promotes T H 1 differentiation and represses T H 2 differentiation 3, 6 . Although several studies have reported an enhanced T H 17 response in Tbx21 −/− mice in various disease models [16] [17] [18] [19] , no mechanistic explanation for this was provided. Here we have demonstrated that T-bet suppressed commitment to the T H 17 lineage by inhibiting transcription of the gene encoding the T H 17 cell-specific transcription factor RORγt and its target genes. T-bet did not directly repress the Rorc promoter. Instead, T-bet interacted with Runx1 and blocked Runx1-mediated transactivation of Rorc. Overexpression of Runx1 was sufficient to reverse the inhibitory effects of T-bet on IL-17A production by T H 17 cells. Furthermore, T-bet Tyr304 was crucial not only for formation of the T-bet-Runx1 complex but also for blocking Runx1 activity and inhibiting the T H 17 differentiation program. Thus, our data have identified a molecular mechanism to explain the exaggerated T H 17 responses observed in T-bet-deficient hosts.
In addition to activating a set of genes that promote the differentiation of helper T cells toward a specific lineage, a master regulator can also suppress the developmental program of the opposing T cell lineages 34 Fig. 5d ). (f) DNA-precipitation assay and immunoblot analysis of HEK293 cells transfected with Myc-tagged Runx1, wild-type T-bet or T-bet(Y304F) in the presence of oligonucleotide containing wild-type or mutated Runx1-or T-bet-binding sites (as in Fig. 5d ), probed with anti-Myc and anti-T-bet. Data are representative of three independent experiments (a-d; mean and s.e.m. in b,d or one experiment (e,f). dendritic cells 26 prompted us to investigate the contribution of T-bet to regulation of the T H 17 response. Our data have shown that T-bet deficiency resulted in an augmented T H 17 response in vitro and in vivo during CNS inflammation in the EAE model of multiple sclerosis. Our results differ from those of published studies reporting that mice injected with T-bet-specific small interfering RNA have lower expression of IL-23R and lack T H 17 cells after immunization with myelin basic protein plus CFA or after immunization with MOG(35-55) plus CFA 35, 36 . We found instead that T H 17 cells were present in the CNS of Tbx21 −/− mice in greater numbers and had high expression of genes encoding T H 17 signature cytokines after induction of EAE via MOG(35-55) plus CFA. The disparity between those studies 35, 36 and our results here may arise from differences in experimental conditions, such as the use of T-bet-specific small interfering RNA rather than complete genetic deletion in vivo. In support of our results, one of the studies noted above also detected a greater frequency of myelin-specific T H 17 cells in Tbx21 −/− mice than wild-type mice after immunization with MOG(35-55) plus CFA 36 . Notably, despite their strong T H 17 response, Tbx21 −/− mice were largely protected from the development of EAE 36 . To explain that observation, we postulate that in the inflammatory milieu of the CNS, T-bet controls the expression of a newly identified set of genes important for the pathogenicity of T H 17 cells but not for the development of T H 17 cells. In support of that hypothesis, a study has reported that T-bet is expressed in IL-23-treated T H 17 cells and that these T-bet-expressing T H 17 cells are pathogenic during CNS inflammation, which indicates the important function of T-bet in a subset of T H 17 cells 37 . Alternatively, the presence of both T H 1 cells and T H 17 cells might be required for CNS pathology. Finally, T-bet expression in other cell types might be important for driving disease development.
Here we focused on the function of T-bet in the commitment of CD4 + T cells to the T H 17 lineage. We found that T-bet overexpression in naive helper T cell precursors or committed T H 17 cells had a negative effect on Rorc transcription and consequently on the expression of RORγt target genes. In addition, we observed downregulation of Il21 expression. T-bet suppresses IL-21 in T H 1 cells by interacting with the transcription factor NFATc2, thus preventing NFATc2 from binding to the Il21 promoter 29 . As IL-21 promotes IL-23R expression in T H 17 cells 10 , T-bet-mediated suppression of Il21 could also contribute to the lower expression of Il23r in T H 17 cells after transduction with a retrovirus expressing T-bet. In contrast to the expression of Rorc, Il17a, Il17f and Il23r, which was suppressed by T-bet, Il22 expression was augmented by ectopic expression of Tbet. The aryl hydrocarbon receptor (AhR) controls IL-22 production by T H 17 cells, as CD4 + T H 17 cells from AhR-deficient mice fail to produce IL-22 when exposed to AhR ligands 38, 39 . Thus, it is plausible that T-bet expression has a synergistic effect on the AhR-mediated induction of IL-22.
We detected binding of endogenous T-bet at a region 2 kb upstream of the first Rorc exon in nonskewed and T H 1 cells but not in T H 17 cells. Notably, differentiation of helper T cells down the T H 1 pathway resulted in much lower expression of Runx1. Conversely, culture of helper T cells in the presence of T H 17-polarizing cytokines resulted in suppression of the expression of T-bet protein. This was not unexpected, as TGF-β has a negative effect on T-bet expression, and IFN-γ, the most potent inducer of T-bet expression, is neutralized under in vitro T H 17-polarizing conditions. Thus, the lack of binding of T-bet to the Rorc promoter in committed T H 17 cells could be explained by much lower expression of T-bet in this helper T cell subset.
We did not detect any substantial effect of T-bet overexpression on Rorc promoter activity in luciferase assays. Evidence that T-bet acts as a direct transcriptional repressor or can recruit corepressors to promoters is lacking at present. However, T-bet can exert a negative regulatory effect on gene expression by blocking the activity of competing transcription factors 15, 26, 27 . Understanding of the transcriptional regulation of Rorc is still incomplete. It has been reported that Rorc expression is much lower in Irf4 −/− and Stat3 −/− CD4 + cells 31, [40] [41] [42] . Runx1 induces Rorc expression, and BATF is important for the maintenance of Rorc expression in stimulated T cells 30, 32 . It is unknown at present whether regulation of Rorc expression by IRF4 and BATF is mediated by direct binding of these transcription factors to the Rorc locus, but the binding sites for STAT3 in the Rorc and Il17a loci have been identified 33 . The binding of STAT3 to both Rorc and Il17a was similar in Tbx21 −/− and wild-type helper T cells. Hence, we focused on the transcriptional activity of Runx1, as we detected two Runx1 consensus sites in the proximity of the site for peak binding of T-bet, 2 kb upstream of the first exon of Rorc, as shown by ChIP.
On the basis of our protein-expression data and coimmunoprecipitation experiments, we propose that the functionally important interaction of T-bet and Runx1 occurs in uncommitted helper T cells. We mapped the function of T-bet in its interaction with Runx1, repression of Runx1 activity and suppression of the T H 17 differentiation program to Tyr304. Our preliminary data indicated that this tyrosine residue was not phosphorylated and that the protein was stably expressed in HEK293 cells and primary T cells. In DNA-precipitation assays, the T-bet(Y304F) mutant failed to bind to DNA. Although Tyr304 was important for the interaction of T-bet with DNA, our results have indicated that this interaction was not essential for the ability of T-bet to block Runx1. Wild-type T-bet was still able to block the binding of Runx1 to its target site in a Rorc promoter bearing a mutated T-bet half-site. Thus, the T-bet-Runx1 (protein-protein) interaction is the main mechanism by which T-bet blocks Runx1 activity by sequestering Runx1 away from the Rorc promoter.
In both infectious and autoimmune diseases, T cell-mediated responses are characterized by the presence of cells coexpressing IL-17A and IFN-γ, the so-called 'IFN-γ + T H 17 cells' . T cell clones from mice immunized with a peptide of myelin basic protein are either T-bet + RORγt − or T-bet + RORγt + (ref. 28) . T-bet + RORγt + cells are very responsive to exogenous cytokines such as IL-12 and IL-23, which influence the relative amounts of T-bet and RORγt and shift cytokine production toward IFN-γ or IL-17A, respectively 28 . The unstable phenotype of T H 17 cells is not restricted to CNS-specific autoimmunity. Studies of IL-17F reporter mice in a transfer model of colitis have demonstrated that IFN-γ-producing CD4 + T cells can emerge from T H 17-committed cells during T cell-driven inflammation. This transition of T H 17 cells into IFN-γ-producing cells is dependent on STAT4 and T-bet 21 . In the context of those findings, we are tempted to propose that this T-bet-mediated transition of T H 17 cells into a 'T H 1-like' subset is controlled partly by T-bet-mediated interference with the transcriptional activity of Runx1. Ectopic expression of T-bet in T H 17 cells results in suppression of Rorc. However, in fully differentiated T H 17 cells, which already express RORγt, T-bet could still interfere with transcriptional activity of RORγt by sequestering its coactivator, Runx1. Overexpression of Runx1 in T H 17 cells overcame the inhibitory effect of T-bet and completely restored IL-17A production. Although Runx1 fully restored IL-17A production, Rorc expression was only slightly higher. These results indicate that there are additional mechanisms by which T-bet inhibits Rorc expression. One potential mechanism could be the induction of repressive epigenetic changes in the Rorc locus by IL-12 signaling, which are dependent on STAT4 and T-bet 43 . Thus, T-bet re-expression in T H 17 cells turns off Rorc expression through the sequestration of Runx1 and through the introduction of epigenetic changes that result in the expression of genes encoding T H 1 signature molecules and acquisition of the 'T H 1-like' phenotype by T H 17 cells.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
